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Abstract
Background: Cancer arises from the consecutive acquisition of genetic alterations. Increasing
evidence suggests that as a consequence of these alterations, molecular interactions are
reprogrammed in the context of highly connected and regulated cellular networks. Coordinated
reprogramming would allow the cell to acquire the capabilities for malignant growth.
Results: Here, we determine the coordinated function of cancer gene products (i.e., proteins
encoded by differentially expressed genes in tumors relative to healthy tissue counterparts,
hereafter referred to as "CGPs") defined as their topological properties and organization in the
interactome network. We show that CGPs are central to information exchange and propagation
and that they are specifically organized to promote tumorigenesis. Centrality is identified by both
local (degree) and global (betweenness and closeness) measures, and systematically appears in
down-regulated CGPs. Up-regulated CGPs do not consistently exhibit centrality, but both types of
cancer products determine the overall integrity of the network structure. In addition to centrality,
down-regulated CGPs show topological association that correlates with common biological
processes and pathways involved in tumorigenesis.
Conclusion: Given the current limited coverage of the human interactome, this study proposes
that tumorigenesis takes place in a specific and organized way at the molecular systems-level and
suggests a model that comprises the precise down-regulation of groups of topologically-associated
proteins involved in particular functions, orchestrated with the up-regulation of specific proteins.
Background
In recent years, functional genomic and proteomic
approaches have generated a vast quantity of data through
which cellular processes, pathways and pathologies can be
deciphered. In particular, microarray-based studies have
provided genome-wide expression data for almost every
type of human cancer [1]. As a consequence of genetic and
molecular analyses, the sequence of events that contrib-
utes to certain types of human cancer, for example color-
ectal cancer [2], is relatively well characterized.
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Although our understanding of the genetic determinants
of tumorigenesis has been greatly enhanced by these
approaches [3], other levels of molecular complexity have
emerged [4-6]. Cancer arises from the consecutive acqui-
sition of genetic alterations that, in general, can be recog-
nized as the combination of the loss of function or
transcriptional down-regulation of particular genes
(tumor suppressor genes) and the activation or transcrip-
tional up-regulation of other genes (oncogenes) [3].
Downstream of the genetic alterations are expression
changes in many genes in cancer cells, mediated in part by
the activation or inactivation of transcription factors [7,8].
It is thought, then, that genetic and molecular alterations
promote tumorigenesis in the context of highly connected
and regulated gene and protein networks [4-6,9]. Cellular
transformation therefore requires dynamic interconnect-
edness, where specific changes in the information cir-
cuitry primarily dictated by up- or down-regulated genes
activate or deactivate pathways and, finally, change the
cell phenotype. In order to develop a systems-level under-
standing of cellular transformation it would therefore be
necessary to determine the properties and organization of
CGPs (proteins encoded by differentially expressed genes
in tumors relative to healthy tissue counterparts) in cellu-
lar networks.
This study examines the topological properties of CGPs in
the human interactome network. Wachi et al. [10] previ-
ously reported increased connectivity of differentially
expressed proteins in lung cancer tissues, and Jonsson and
Bates (2006) [11] reported differences in the global topo-
logical features of mutated cancer proteins relative to non-
mutated proteins. However, there is no comprehensive
study of different cancer types that examines both the
local and global topological properties of CGPs and their
organization relative to the structural integrity of the net-
work and to molecular mechanisms of tumorigenesis. The
results of these analyses suggest that CGPs are central to
information exchange and propagation, and that their
topological organization supports fundamental biologi-
cal processes of neoplasia.
Results
Integration of interactome and cancer transcriptomes
To investigate the systems-level organization of CGPs, we
integrated interactome and cancer transcriptome data sets
(Figure 1). The interactome data set contains compiled
and filtered binary human protein-protein interactions
from all currently available databases (HPRD, BIND, DIP,
MINT, INTACT and MIPS; detailed in Gandhi et al. [12]).
This data set is mainly derived from one-at-a-time experi-
mentally demonstrated interactions compiled through a
literature curation process [13], which suggests a high
degree of reliability. The corresponding scale-free interac-
tome network contains 7,388 proteins and 24,109 inter-
actions, which follow a power-law distribution with an
average degree of 6.52 (Additional file 1). The longest dis-
tance between any two proteins is 15 and the average dis-
tance is 4.50. This interactome network constitutes a
scaffold in which different types of functional genomics
data can be integrated to ascertain the coordinated func-
tion of proteins under particular conditions.
To analyze cancer transcriptomes, we chose data sets of
high-incidence cancer types containing a large number of
tumors and healthy tissue samples in order to obtain
more consistent gene lists (data sets with at least 10 sam-
ples of each type). Four expression data sets were ana-
lyzed, corresponding to prostate, lung and colorectal
samples [14-17] (Additional file 2). We first focused our
analysis on the prostate data sets because they were inde-
pendently generated and contain publicly available raw
data, which meant an identical statistical methodology
could be applied for differential gene expression detection
and to replicate findings [14,15]. These data sets contain
data for 50 healthy tissue samples each and for 52 and 38
tumor samples, respectively. Differentially expressed
genes between healthy and tumor samples were then
identified using an empirical Bayes moderated t-test and
adjusting P values with a false discovery rate of 5%. Thus,
1,429 and 981 CGPs encoded by up- and down-regulated
genes in prostate tumors were mapped in the interactome
network, respectively. Up- and down-regulated gene sets
overlapped between studies by 50.33% and 41.05%,
respectively. Accordingly, both studies also showed a sim-
ilar distribution of Gene Ontology (GO) [18] terms anno-
tation in the complete gene ranking (Additional file 3),
which essentially supports a good agreement between the
expression data sets. The numbers of differentially
expressed genes obtained in this analysis are consistent
with the numbers given in the original publications. A
comparison of healthy and tumor tissues is likely to reveal
more dramatic expression differences than a comparison
of tumor subtypes, thus identifying differentially
expressed genes that are involved in all stages of the neo-
plastic process.
In order to extend the analysis to different types of CGPs,
we used expression data sets derived from the study of
lung samples (230 tumors and 17 healthy), which
included different cellular types, and colorectal samples
(18 tumors and 36 healthy) [16,17]. The lung expression
data set was analyzed using the same statistical methodol-
ogy as described for the prostate, while genes differentially
expressed in colorectal tumors identified on a different
microarray platform were taken from a public repository
[19]. Sets of differentially expressed probes for each cancer
type are detailed in (Additional file 2). Integration of the
human interactome and cancer transcriptomes was then
completed by matching GeneIDs.BMC Genomics 2007, 8:185 http://www.biomedcentral.com/1471-2164/8/185
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Centrality of CGPs
Analysis of the topological properties of CGPs in the inter-
actome network was focused on centrality by measuring:
i/ degree, which accounts for the total number of first
interactions; ii/ betweenness, which accounts for the fre-
quency with which a node in a network is found in the
shortest path between any two other nodes; and iii/ close-
ness, which accounts for the proximity of a node to all
other nodes in a network. To determine the significance of
each measure, we compared the median of CGPs to the
median of the total of nodes in the network using the
Mann-Whitney U test. We also compared the results to
equivalent randomly selected protein sets in the interac-
tome.
The analysis of prostate CGPs revealed higher values for
degree, betweenness and closeness than in the complete
interactome set (Mann-Whitney U test P values < 10-5) or
equivalent randomly selected sets (empirical P values <
0.01) (Figure 2 and Additional file 4). The results for the
two prostate expression data sets were concordant. Impor-
tantly, higher values of centrality for lung and colorectal
CGPs were also observed (Additional file 4). These results
indicate that centrality in the interactome network is a
common property of proteins encoded by differentially
expressed genes in tumors relative to healthy tissue coun-
terparts.
To further examine the topological properties of CGPs, we
analyzed the manner in which they are related to their
neighbors by examining their constraint, which accounts
for the dependency of a node on its neighborhood. CGPs
showed significantly lower average values of this measure
(Mann-Whitney U test P values < 10-7; empirical P values
< 0.01) (Additional file 4). CGPs therefore appear to act
independently of their neighborhood, which supports the
importance of these products in terms of information
exchange and propagation within the interactome net-
work studied.
Following this, we analyzed whether the topological
properties of CGPs were mainly determined by one spe-
cific type of differentially expressed gene (i.e. up-regulated
or down-regulated). This analysis highlighted that central-
ity is a property consistently found in down-regulated
CGPs, while results for up-regulated CGPs were not con-
Study strategy Figure 1
Study strategy. Integration of binary protein-protein interactions and gene expression data sets for the investigation of the top-
ological properties and organization of cancer gene products (CGPs) in the human interactome network.
+XPDQELQDU\
SURWHLQLQWHUDFWLRQV +XPDQLQWHUDFWRPHQHWZRUN
3URWHLQVQ
3
U
R
W
H
L
Q
V


Q

+XPDQJHQH
H[SUHVVLRQGDWD
WXPRUDQGKHDOWK\WLVVXHV
'LIIHUHQWLDOO\
H[SUHVVHGJHQHV
LQWXPRUV
7RSRORJLFDOSURSHUWLHVDQGRUJDQL]DWLRQ
RIFDQFHUJHQHSURGXFWV&*3VBMC Genomics 2007, 8:185 http://www.biomedcentral.com/1471-2164/8/185
Page 4 of 12
(page number not for citation purposes)
clusive (Additional file 5). The fact that up-regulated
CGPs do not show consistent centrality measures could be
the result of technical or biological differences between
studies, for example that prostate tumor samples were col-
lected at different stages [14,15]. On the other hand, this
observation might also suggest that down-regulation
plays a major role in tumorigenesis at the interactome net-
work level.
Possible centrality differences between cancer subtypes
were investigated by analyzing the lung data set according
to the pathological description of tumors (adenoid, carci-
noid, and squamous) [17]. Overlaps of 50.55%, 74.94%
and 50.48%, respectively, were observed for adenoid-car-
cinoid, adenoid-squamous, and carcinoid-squamous
down-regulated CGPs sets. In this case, all three subtypes
showed centrality measures consistent with the analysis of
prostate and colorectal down-regulated CGPs (Additional
file 4). Once again, up-regulated CGPs showed heteroge-
neity of average values and value distributions.
Centrality analysis using different sets of experimentally- 
or computationally-generated interactions
Comparison of publicly available protein-protein interac-
tion repositories has revealed small, although significant,
overlaps and considerable selection and detection bias
[20,21]. To evaluate the consistency of the above results,
we performed similar centrality analyses using three dif-
ferent sets of experimentally- or computationally-gener-
ated interactions: i/ in vivo experimental interactions only;
ii/ interactions with two or more experimental evidences
as compiled by Gandhi et al. [12] (interactions found in
vivo and/or in vitro, including yeast two-hybrid interac-
tions); and iii/ computationally-generated interactions
using a homology-based method [22]. This final data set
was carefully validated using true positive interactions
Centrality of CGPs Figure 2
Centrality of CGPs. Results of the Mann-Whitney U test (MW) are shown at the top right in each box. Results of comparing 
each centrality measure between prostate CGPs (vertical arrow; mean value) and 1,000 equivalent randomly selected protein 
sets (curves; mean values) (data sets 1 [14] and 2 [15]) are also shown. CGPs mean values and 95% confidence intervals (CI), as 
well consequent empirical P values are shown.
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sourced from the HPRD database and false positive inter-
actions for proteins localized in incompatible cellular
compartments based on Gene Ontology (GO) annota-
tions [11]. Using these three interactions sets, the number
of nodes and edges in each network were 6,022 and
15,990; 5,009 and 9,950; and 10,691 and 57,846, respec-
tively.
Centrality was then examined in each network for CGPs
of the two prostate cancer data sets, the lung cancer data
set including three pathological sub-classes, and the color-
ectal cancer data set referred to above, distinguishing
between down- and up-regulated CGPs. Importantly, the
results of these analyses are fully consistent with increased
local and global centrality and with lower constraint of
CGPs, particularly for down-regulated CGPs (Additional
file 6). In addition, the results using the homology-based
network also showed increased centrality and lower con-
straint for up-regulated CGPs. This observation may be
due to the higher number of nodes and edges in the net-
work, which could diminish sampling errors relative to
the anticipated complete interactome or, in contrast, to an
unknown intrinsic bias of the homology-based method.
Overall, analysis of the three interactome data sets further
supports the hypothesis that high centrality is a funda-
mental property of CGPs.
CGPs attack and interactome structure integrity
To better understand the relative importance of each cen-
trality measure for CGPs, a strategy was used that con-
sisted of determining the structural integrity of the
interactome network after removing nodes with different
topological characteristics [23-25]. We calculated the
number of proteins remaining in the main component of
the network (i.e., the part containing the largest number
of connected proteins) after removing CGPs, selected
nodes with the same degree distribution as CGPs but with
lower values of betweenness and closeness centrality, and,
in extreme cases, the hubs (proteins with the highest
degrees).
As expected from the association between centrality and
vulnerability [23,24], removing CGPs had a lesser effect
on structure integrity than did hubs removal. However,
removing CGPs always produced a more dramatic effect
than removing selected nodes with the same degree distri-
bution but with lower values of betweenness and close-
ness. The number of proteins remaining in the main
component was consistently smaller when CGPs were
removed than when these selected nodes were removed
(Figure 3 and Table 1). After deleting n nodes, the size of
the main component is not only reduced by n but also by
other nodes that are attached to CGPs. For example,
removing 795 down-regulated prostate CGPs reduced the
total number of nodes in the main component by 1,026
(7,092 to 6,066), while removing 795 proteins with the
same degree distribution but with lower values of
betweenness and closeness reduced the total number of
nodes by 682 (7,092 to 6,410). Although the differences
affect a small percentage of nodes in the main component
CGPs attack and interactome network structure integrity Figure 3
CGPs attack and interactome network structure integrity. Interactome network examples after removing an equivalent 
number of hubs, prostate down-regulated CGPs (data set 1 [14]) or selected proteins with the same degree distribution as 
CGPs, but with lower values of betweenness and closeness. Disconnected nodes from the main component are shown in inset 
to emphasize the difference between CGPs and selected proteins.
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(5.6% to 1.5%), the same tendency was observed for all
the up- and down-regulated CGP sets examined (12 in
total). These results suggest that the positions of both
types of CGPs in the interactome network are more
important than their degree distributions reflect.
Topological and functional association of CGPs
Using the experimentally-based data sets, analysis of the
level of inter-connection with neighboring proteins
through the average clustering coefficient (CC) and by
examining cliques (i.e. fully connected network sub-
graphs) did not reveal significant over-representation of
CGPs when corrected by multiple testing (not shown). In
agreement with the lower constraint values observed,
these observations suggest that CGPs perform their sys-
tems-level function principally by exploiting centrality
(degree, betweenness and closeness), although not by vir-
tue of being highly inter-connected in their neighbor-
hood. However, the same analysis using the homology-
based data set revealed significant differential CC values
for both down- and up-regulated CGPs in different tumor
types (Additional file 6). Larger, experimentally-based
data sets are therefore needed to clarify the reasons for this
discrepancy.
Next, we assessed whether the average network distances
between CGPs were lower than the average in the main
component. Thus, we determined the shortest distance
between CGPs and compared this to the shortest distance
between any two proteins in the main component. Lower
distances were observed between CGPs – up-regulated,
down-regulated, or both – when compared to the average
distance in the main component (4.09 – 4.34 against
4.50, respectively) (Table 2). Accordingly, the maximum
distances between CGPs were always found to be smaller
than the maximum distance between any two proteins in
the main component (10–12 against 15, respectively).
These results suggest the topological association of CGPs
regardless of CC or up/down-regulation.
Distances between CGPs can be represented in a matrix
format where clusters are identified (Figure 4a and Addi-
tional file 7). We then investigated whether these topolog-
ical associations or clusters of CGPs have functional
implications for mechanisms of tumorigenesis. In this
analysis, proportions of GO terms [18] and pathway
(KEGG) [26] annotations were compared between clus-
ters showing small network distances (≤ 3 shortest dis-
tance) and the remaining CGPs (≥ 4 )  i n  e a c h  m a t r i x .
Results showed that down-regulated CGPs in clusters par-
ticipate in common biological processes or pathways
involved in tumorigenesis (Table 3). Thus, the GO analy-
sis revealed the coordinated down-regulation of CGPs
involved in cell adhesion and cell communication proc-
esses, which would facilitate the metastatic behavior of
cancer cells, and the coordinated down-regulation of
CGPs involved in programmed cell death, which would in
turn prolong cancer cell life and allow tumorigenesis to
Table 1: Interactome attack
Number of nodes remaining in the main component after selective removal of:
N* Hubs CGPs Same degree nodes Difference**
Prostate cancer
Data set 1 Down-regulated 795 4,092 6,066 6,410 344
Up-regulated 634 4,616 6,294 6,610 316
Data set 2 Down-regulated 574 4,826 6,312 6,591 279
Up-regulated 407 5,346 6,586 6,807 221
Lung cancer
Adenoid Down-regulated 476 5,112 6,460 6,719 259
Up-regulated 187 6,134 6,830 6,966 136
Carcinoid Down-regulated 786 4,119 5,965 6,368 403
Up-regulated 518 5,002 6,421 6,736 315
Squamous Down-regulated 458 5,171 6,479 6,716 237
Up-regulated 525 4,974 6,380 6,640 260
Colorectal cancer
Down-regulated 164 6,220 6,849 6,960 111
Up-regulated 289 5,726 6,709 6,858 149
*Number of CGPs mapped on the complete human interactome (i.e. number of nodes removed in this analysis)
**Main component difference between removing nodes with the same degree distribution as CGPs but with lower values of betweenness and 
closeness, and CGPsBMC Genomics 2007, 8:185 http://www.biomedcentral.com/1471-2164/8/185
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progress by accumulating genetic and molecular altera-
tions. KEGG analysis revealed the coordinated down-reg-
ulation of pathways commonly associated with
tumorigenesis, such as the extracellular matrix-receptor
interaction pathway. It also revealed the coordinated
down-regulation of pathways known to play a critical role
in prostate carcinogenesis, for example the insulin signal-
ing pathway [27].
Most up-regulated CGP topological associations did not
show significant enrichment in GO or KEGG annotations,
however, when all CGPs were considered together, both
up- and down-regulated CGPs participating in common
biological processes and pathways were found closely
located in the network. For example, up- and down-regu-
lated CGPs within and connecting cell communication
and cell adhesion functions are protein kinase C isozymes
(Figure 4b), which are well known regulators of cell pro-
liferation and transformation of prostate epithelial cells
[28]. This CGP organization might reflect a change in the
flow of information between different processes so as to
promote tumorigenesis.
Discussion
A criterion of centrality for a particular node in a network
can be given by local (degree) or by global (betweenness
and closeness) measures. A higher degree does not neces-
sarily mean that a node is more important for information
exchange and propagation, so more global measures are
needed than degree measures. The three measures of cen-
trality therefore reflect the possibilities of a particular pro-
tein choosing alternative paths, acting as a broker between
different proteins, for example connecting distinct com-
plexes or signaling pathways, or being closer to any other
proteins for information propagation. By virtue of central-
ity, the hundreds of differentially expressed proteins in
tumors are likely to promote tumorigenesis at the interac-
tome network level in a coordinated manner. Viewed
alternatively, proteins with a less central position within
the interactome network might not be able to have a glo-
bal impact on the cellular behavior determined by the
protein-protein interactions involved in cellular transfor-
mation.
Table 3: Topological and functional association of prostate 
CGPs
Non-redundant significant terms* GO level P value 
FDR-
adjusted
Data set 1
Cluster A
BP: Protein amino acid phosphorylation 8 9.12E-03
CC: Plasma membrane 4 2.25E-02
MF: Protein-tyrosine kinase activity 7 9.12E-03
Cluster B
BP: Cell-matrix adhesion 5 4.29E-02
CC: Extracellular space 3 4.09E-04
MF: Metalloendopeptidase inhibitor activity 6 3.75E-03
Cluster C
BP: Intracellular signaling cascade 5 3.74E-02
CC: Cytoskeleton 4 4.11E-02
MF: Protein-tyrosine kinase activity 7 1.76E-03
KEGG: T cell receptor signaling pathway 1.18E-02
Adherens junction 2.21E-02
Focal adhesion 4.11E-02
Cluster D
BP: Macromolecule biosyntesis 5 3.17E-02
CC: Cytosolic ribosome 5 2.30E-02
MF: Structural constituent of ribosome 7 6.86E-03
KEGG: Ribosome 6.86E-03
Data set 2
Cluster E
MF: Purine nucleotide binding 4 1.51E-03
Cluster F
CC: Extracellular space 3 8.00E-03
MF: Extracellular matrix structural 
constituent
3 8.00E-03
KEGG: Extracellular matrix receptor 
interaction
8.00E-03
Cluster G
BP: Regulation of programmed cell death 5 4.32E-02
MF: Protein kinase activity 6 2.18E-02
KEGG: Insulin signaling pathway 4.62E-02
Cluster H
BP: Phosphate transport 8 1.27E-02
CC: Extracellular space 3 1.10E-12
MF: Metalloendopeptidase inhibitor activity 6 3.05E-02
KEGG: Extracellular matrix receptor 
interaction
2.07E-03
*BP (Biological Process), CC (Cellular Component), MF (Molecular 
Function), KEGG (Kyoto Encyclopedia of Genes and Genomes)
Table 2: Topological association of prostate CGPs
Network distance
N* Shortest 
(average)
Maximum
Data set 1 Down-regulated 773 4.27 12
Up-regulated 608 4.09 10
All 1,381 4.22 12
Data set 2 Down-regulated 565 4.14 11
Up-regulated 392 4.34 11
All 957 4.23 12
Main component 7,092 4.50 15
*Number of CGPs in the main componentBMC Genomics 2007, 8:185 http://www.biomedcentral.com/1471-2164/8/185
Page 8 of 12
(page number not for citation purposes)
Topological and functional association of CGPs Figure 4
Topological and functional association of CGPs. (a). Matrices of network distances between prostate CGPs (three categories: 
< 4 shortest distance shown in red; 4–6 shown in green; and > 6 shown in blue). CGP matrix clusters with significant enrich-
ment in GO or KEGG annotations involved in tumorigenesis-related processes are indicated. (b). Functional association of 
prostate CGPs. Cell communication (cluster C) and cell death (cluster G) biological processes are shown. Green, red and black 
nodes correspond to down-regulated, up-regulated, and non-differentially expressed proteins, respectively. Dashed circles and 
lines connect proteins common to both processes. Protein kinase C isozymes are denoted by the prefix PRKC.
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Protein-protein interactions repositories are incomplete
and not fully reliable, based on the observed selection and
detection biases [20,21]. Gandhi et al. [12] demonstrated
that there is minimal overlap across currently known
experimental species interactome data sets. In addition,
recent work by Mika and Rost [29] has shown that inter-
actions are more conserved within species than across spe-
cies and that homology transfers are only accurate at high
levels of identity. These observations raise the question of
the specificity and sensitivity of large-scale homology-
based generated interactomes with respect to other
approaches. The principle of conserved protein-protein
interactions or "interologs" was first used by Matthews et
al. [30] and subsequently extended by several authors [31-
33]. The Jonsson et al. [11,22] data set used in the present
study applied a new confidence score to predict interac-
tions, which was based on both the level of homology and
the amount of experimental data available that supported
a particular interaction. By benchmarking the score the
authors obtained relatively good percentages of sensitivity
and specificity (~80–85%) for a reasonable cut-off [11],
which indicates high reliability of the data set. This obser-
vation corroborates our results by replicating the findings
with respect to centrality.
In addition to selection and detection biases, the limited
coverage of current data sets relative to the anticipated
complete human interactome suggests that results derived
from any currently available set should be interpreted
with an element of caution, as has been demonstrated for
other well-established topology characteristics [34]. The
results using the Jonsson et al. [22] data set show
increased centrality for up-regulated CGPs and differential
CC values that were not consistently observed when using
other interaction sets. The larger size of this data set could
reduce the effect of sampling and may facilitate the detec-
tion of weak effects. This apparent discrepancy will prob-
ably remain unexplained until larger coverage of the
anticipated human experimental interactome has been
obtained. Nevertheless, we analyzed hundreds of CGPs,
most of which belonged to different sets across different
cancer types, which makes this study less likely to present
a bias in gene selection.
In a previous study focused on lung cancer, it was sug-
gested that up-regulated CGPs in squamous lung tumors
have higher connectivity [10], yet the same observation
was not supported for down-regulated CGPs. This discrep-
ancy could be due to the small number of samples pro-
filed (five tumors and matched healthy tissues) but also to
the examination of another interactome network gener-
ated mainly from computationally-generated interac-
tions. On the other hand, the lung data set we used [17]
has been extensively examined and validated, which sug-
gest that the apparent centrality inconsistency of down-
regulated CGPs is not due to the existence of different sub-
sets of lung CGPs.
This study proposes a model for systems-level molecular
mechanisms of tumorigenesis that includes the down-reg-
ulation of specific biological processes represented by top-
ological associations of CGPs in the interactome network,
combined with the up-regulation of particular proteins
that could depend on the cell type, tumor type or tumor
stage. Since we analyzed tumor panels, our results reflect
average, possibly secondary molecular events in cancer.
These changes are initiated by combinations of genetic
alterations in tumor suppressor genes and oncogenes,
which lead to extensive downstream variation of expres-
sion modules carrying specific functions in cancer cells
[7,8]. The analysis of tumors ordered in stages would pro-
vide additional information on the systems-level molecu-
lar mechanisms of cancer progression. The final outcome
of CGP organization could be a change in the flow of
information, specific to each cancer type that will deter-
mine the neoplastic process. Centrality could then be used
in combination with dynamic information (i.e., gene or
pathway up- or down-regulation) to specifically disrupt
cancer cell networks by disturbing proteins that are critical
to both aspects.
Conclusion
Taking into account the current limited coverage of the
anticipated, complete human interactome, this study sug-
gests that the proteins encoded by differentially expressed
genes in tumors relative to healthy tissue counterparts
occupy central positions in the interactome network. Our
results suggest a systems-level tumorigenesis model that
comprises the precise down-regulation of groups of topo-
logically-associated proteins involved in particular func-
tions, orchestrated with the up-regulation of specific
proteins.
Methods
Human interactome network
In generating the human interactome network, a previ-
ously compiled data set was used, mainly containing
experimentally demonstrated interactions compiled
through a literature-curation process, combined with data
from different types of experimental and computational
evidence [12]. In our analyses, proteins with no assigned
Entrez GeneID were excluded, thus yielding a final inter-
actome network containing 7,388 proteins and 24,109
interactions. The network was analyzed using Cytoscape
[35] and UCINET [36]. In removing network hubs, pro-
teins were selected from the highest degree value (> 9
when analyzing prostate CGPs to > 19 when analyzing
colorectal CGPs). The number of proteins/nodes removed
from the network in each case was identical amongst
hubs, CGPs and selected proteins with the same degreeBMC Genomics 2007, 8:185 http://www.biomedcentral.com/1471-2164/8/185
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distribution as CGPs but with lower values of between-
ness and closeness.
Gene expression analysis
The GEPAS package [37] was used for the analysis of
expression data. Background correction, normalization
and averaging of expression values were performed with
the Robust Multi-array Average (RMA) algorithm [38].
Differentially expressed genes between healthy and tumor
samples were declared after the calculation of an empiri-
cal Bayes moderated t-statistic, and P values adjusted by
false discovery rate of 5%. Previously analyzed colorectal
data [16] were down-loaded from a public repository
[19]. Data sets and probe lists are detailed in Table S1. The
FatiScan tool [39] was used to assess enrichment of GO
terms in the complete gene ranking according to the
empirical Bayes moderated t-statistic.
Topological analysis
The degree of a vertex or protein in the interactome net-
work was calculated by counting the number of edge-ends
at that node. Betweenness was calculated in accordance
with Freeman's formulation [40]. Thus, betweenness cen-
trality CB(v) for vertex v is calculated as follows:
where σst is the number of shortest geodesic paths from s
to t and σst (v) the number of shortest geodesic paths from
s to t that pass through the vertex v. This value was normal-
ized by dividing by (n -1) × (n - 2), where n is the number
of vertices. Closeness centrality was calculated according
to Sabidussi's formulation [41]. Thus, the closeness CC(v)
for a vertex v is the reciprocal of the sum of geodesic dis-
tances to all other vertices in graph G, and is calculated as
follows:
Hierarchy and constraint were calculated using Burt's for-
mulation [42]. Constraint is a summary measure that
indicates the level of independence of a node from its
neighbourhood, depending on the number of edges that
connect it to neighbour nodes. Thus, constraint is calcu-
lated as follows:
for q ≠ i, j, where pij is the proportion of node i connec-
tions to j. Hierarchy is the extent to which constraint is
concentrated in a single node and is calculated as follows:
The cluster coefficient is the local density of a node's con-
nections and is defined as the ratio between the observed
number of connections Li and the total number of possi-
ble connections for a particular node i, ki (ki - 1). Thus, the
clustering coefficient is calculated as follows:
The Bron and Kerbosch algorithm [43] was used to find all
cliques greater than a specified size [44].
To assess significance, the non-parametric Mann-Whitney
U test was used to determine whether the median of the
centrality measures was different between protein sets. To
assess significance, the properties of CGPs were also com-
pared to equivalent, randomly selected protein sets in the
interactome. One thousand random iterations were per-
formed in each case. Subsequently, average values, confi-
dence intervals and empirical P values were obtained.
Functional association analysis
The Stats and Graphics packages in R [45] were used to
analyze and plot the matrix of network distances between
CGPs, respectively. Hierarchical clustering with an average
linkage method was applied to the matrix so as to arrange
CGPs according to their network distances. The FatiGO+
tool [46] was then used to assess GO and KEGG annota-
tions enrichment between the set of CGPs within a partic-
ular cluster and the remaining CGPs in the same matrix.
Calculated P  values were adjusted by FDR, taking into
account the total number of genes interrogated in each
case.
Authors' contributions
PH participated in the study design, compiled and ana-
lyzed the gene expression and protein-protein interaction
data sets, and helped to draft the manuscript. JHC partic-
ipated in the study design and performed microarray anal-
yses. DM, FAS and JV helped with microarray and
statistical analyses. LG and GC participated in scientific
discussions. GC provided institutional and grant sup-
ports. MAP and JD conceived the study. JHC and JD
helped to draft the manuscript. MAP designed and coordi-
nated the study, and wrote the original and final versions
of the manuscript. All authors read and approved the final
version of the manuscript.
Cv
v
B
st
st
svtV ()
()
= ≠≠ ∈ ∑
σ
σ
Cv
dv t
C
G tV
()
(,)
=
∈ ∑
1
cp p p ij ij iq qj q =+ ( ) ∑
2
H
c
CN
c
CN
NN
ij ij
j
=
⎛
⎝
⎜
⎞
⎠
⎟
⎛
⎝
⎜
⎞
⎠
⎟ ∑ /
ln
/
ln
Ci
L
ki ki
i ()
()
=
−
2
1BMC Genomics 2007, 8:185 http://www.biomedcentral.com/1471-2164/8/185
Page 11 of 12
(page number not for citation purposes)
Additional material
Acknowledgements
We are grateful to C. Lázaro, Adolfo A. Ferrando and E. Serra for valuable 
discussions, and to three anonymous reviewers for their helpful criticism. 
We are also extremely grateful to all those involved in the maintenance of 
publicly available protein-protein interactions databases. MAGP would like 
to offer his personal thanks to Marc Vidal, for introducing him to and devel-
oping his knowledge of the world of systems biology. This work was sup-
ported by the Fundació la Caixa (grant BM05-254-00 awarded to MAGP), 
the Catalan Institute of Oncology (PH), the Spanish Ministry of Education 
and Science (grant BIO2005-01078 awarded to JD), the NRC Canada-SEP-
OCT Spain and the National Institute of Bioinformatics a platform of 
Genome Spain. MAGP is a Ramón y Cajal Researcher with the Spanish Min-
istry of Education and Science. JHC and DM are supported by the Fun-
dación Genoma España.
References
1. Liu ET: Classification of cancers by expression profiling.  Curr
Opin Genet Dev 2003, 13(1):97-103.
2. Sancho E, Batlle E, Clevers H: Signaling pathways in intestinal
development and cancer.  Annu Rev Cell Dev Biol 2004,
20:695-723.
3. Hanahan D, Weinberg RA: The hallmarks of cancer.  Cell 2000,
100(1):57-70.
4. Khalil IG, Hill C: Systems biology for cancer.  Curr Opin Oncol
2005, 17(1):44-48.
5. Kitano H: Cancer as a robust system: implications for antican-
cer therapy.  Nat Rev Cancer 2004, 4(3):227-235.
6. Barabasi AL, Oltvai ZN: Network biology: understanding the
cell's functional organization.  Nat Rev Genet 2004, 5(2):101-113.
7. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Barrette TR, Ghosh
D, Chinnaiyan AM: Mining for regulatory programs in the can-
cer transcriptome.  Nat Genet 2005, 37(6):579-583.
8. Segal E, Friedman N, Koller D, Regev A: A module map showing
conditional activity of expression modules in cancer.  Nat
Genet 2004, 36(10):1090-1098.
9. Rhodes DR, Chinnaiyan AM: Integrative analysis of the cancer
transcriptome.  Nat Genet 2005, 37 Suppl:S31-7.
10. Wachi S, Yoneda K, Wu R: Interactome-transcriptome analysis
reveals the high centrality of genes differentially expressed
in lung cancer tissues.  Bioinformatics 2005, 21(23):4205-4208.
11. Jonsson PF, Bates PA: Global topological features of cancer pro-
teins in the human interactome.  Bioinformatics 2006,
22(18):2291-2297.
12. Gandhi TK, Zhong J, Mathivanan S, Karthick L, Chandrika KN, Mohan
SS, Sharma S, Pinkert S, Nagaraju S, Periaswamy B, Mishra G, Nanda-
kumar K, Shen B, Deshpande N, Nayak R, Sarker M, Boeke JD, Par-
migiani G, Schultz J, Bader JS, Pandey A: Analysis of the human
protein interactome and comparison with yeast, worm and
fly interaction datasets.  Nat Genet 2006, 38(3):285-293.
13. Peri S, Navarro JD, Kristiansen TZ, Amanchy R, Surendranath V,
Muthusamy B, Gandhi TK, Chandrika KN, Deshpande N, Suresh S,
Rashmi BP, Shanker K, Padma N, Niranjan V, Harsha HC, Talreja N,
Vrushabendra BM, Ramya MA, Yatish AJ, Joy M, Shivashankar HN,
Kavitha MP, Menezes M, Choudhury DR, Ghosh N, Saravana R, Chan-
dran S, Mohan S, Jonnalagadda CK, Prasad CK, Kumar-Sinha C, Desh-
pande KS, Pandey A: Human protein reference database as a
discovery resource for proteomics.  Nucleic Acids Res 2004,
32(Database issue):D497-501.
Additional File 1
(Figure S1). Human interactome network characteristics. Scale-free and 
degree distribution. The probability that a protein is connected to k other 
proteins is described by P(k).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-185-S1.pdf]
Additional File 2
(Table S1). Gene expression data set descriptions and differentially 
expressed probe sets.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-185-S2.xls]
Additional File 3
File 3 (Figure S2). FatiScan analysis of prostate gene expression data 
sets. Annotations of Biological Process, Cellular Component and Molecu-
lar Function GO terms (level 3) in the complete gene ranking are shown.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-185-S3.pdf]
Additional File 4
File 4 (Table S2). Statistical analysis results for centrality, constraint, 
and cluster coefficient using the interactome data set described by Gandhi 
et al. [12].
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-185-S4.xls]
Additional File 5
File 5 (Figure S3). Centrality of down- (green arrows) and up-regulated 
(red arrows) prostate CGPs. Results of the Mann-Whitney U test (MW) 
are shown at the top right in each box. Results of comparing each central-
ity measure between prostate CGPs (vertical arrow; mean value) and 
1,000 equivalent randomly selected protein sets (curves; mean values) 
(data sets 1 [14] and 2 [15]) are also shown. CGPs mean values and 
95% confidence intervals (CI), as well consequent empirical P values are 
shown.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-185-S5.pdf]
Additional File 6
File 6 (Table S3). Statistical analysis results for centrality, constraint, 
and cluster coefficient using three interactome data sets: i/ in vivo exper-
imental interactions only; ii/ interactions with two or more in vivo or in 
vitro experimental evidences as compiled by Gandhi et al. [12]; and iii/ 
computationally-generated interactions using a homology-based method 
[22].
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-185-S6.xls]
Additional File 7
File 7 (Figure S4). Topological and functional association of lung and 
colorectal CGPs. Matrices of distances between CGPs (three categories: < 
4 shown in red; 4–6 shown in green; and > 6 shown in blue) and GO and 
KEGG annotations enriched in matrix clusters are shown.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-185-S7.pdf]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Genomics 2007, 8:185 http://www.biomedcentral.com/1471-2164/8/185
Page 12 of 12
(page number not for citation purposes)
14. Singh D, Febbo PG, Ross K, Jackson DG, Manola J, Ladd C, Tamayo P,
Renshaw AA, D'Amico AV, Richie JP, Lander ES, Loda M, Kantoff PW,
Golub TR, Sellers WR: Gene expression correlates of clinical
prostate cancer behavior.  Cancer Cell 2002, 1(2):203-209.
15. Stuart RO, Wachsman W, Berry CC, Wang-Rodriguez J, Wasserman
L, Klacansky I, Masys D, Arden K, Goodison S, McClelland M, Wang
Y, Sawyers A, Kalcheva I, Tarin D, Mercola D: In silico dissection
of cell-type-associated patterns of gene expression in pros-
tate cancer.  Proc Natl Acad Sci U S A 2004, 101(2):615-620.
16. Notterman DA, Alon U, Sierk AJ, Levine AJ: Transcriptional gene
expression profiles of colorectal adenoma, adenocarcinoma,
and normal tissue examined by oligonucleotide arrays.  Can-
cer Res 2001, 61(7):3124-3130.
17. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd
C, Beheshti J, Bueno R, Gillette M, Loda M, Weber G, Mark EJ, Lander
ES, Wong W, Johnson BE, Golub TR, Sugarbaker DJ, Meyerson M:
Classification of human lung carcinomas by mRNA expres-
sion profiling reveals distinct adenocarcinoma subclasses.
Proc Natl Acad Sci U S A 2001, 98(24):13790-13795.
18. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM,
Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-
Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M,
Rubin GM, Sherlock G: Gene ontology: tool for the unification
of biology. The Gene Ontology Consortium.  Nat Genet 2000,
25(1):25-29.
19. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D,
Barrette T, Pandey A, Chinnaiyan AM: ONCOMINE: a cancer
microarray database and integrated data-mining platform.
Neoplasia 2004, 6(1):1-6.
20. Mathivanan S, Periaswamy B, Gandhi TK, Kandasamy K, Suresh S,
Mohmood R, Ramachandra YL, Pandey A: An evaluation of human
protein-protein interaction data in the public domain.  BMC
Bioinformatics 2006, 7 Suppl 5:S19.
21. Futschik ME, Chaurasia G, Herzel H: Comparison of human pro-
tein-protein interaction maps.  Bioinformatics 2007,
23(5):605-611.
22. Jonsson PF, Cavanna T, Zicha D, Bates PA: Cluster analysis of net-
works generated through homology: automatic identifica-
tion of important protein communities involved in cancer
metastasis.  BMC Bioinformatics 2006, 7:2.
23. Albert R, Jeong H, Barabasi AL: Error and attack tolerance of
complex networks.  Nature 2000, 406(6794):378-382.
24. Jeong H, Mason SP, Barabasi AL, Oltvai ZN: Lethality and central-
ity in protein networks.  Nature 2001, 411(6833):41-42.
25. Han JD, Bertin N, Hao T, Goldberg DS, Berriz GF, Zhang LV, Dupuy
D, Walhout AJ, Cusick ME, Roth FP, Vidal M: Evidence for dynam-
ically organized modularity in the yeast protein-protein
interaction network.  Nature 2004, 430(6995):88-93.
26. Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M,
Kawashima S, Katayama T, Araki M, Hirakawa M: From genomics
to chemical genomics: new developments in KEGG.  Nucleic
Acids Res 2006, 34(Database issue):D354-7.
27. Papatsoris AG, Karamouzis MV, Papavassiliou AG: Novel insights
into the implication of the IGF-1 network in prostate cancer.
Trends Mol Med 2005, 11(2):52-55.
28. Gon za l e z - Gue r r i co  A M ,  M e s hk i  J ,  Xi a o  L,  B e n a vi d e s  F ,  Co nt i CJ ,
Kazanietz MG: Molecular mechanisms of protein kinase C-
induced apoptosis in prostate cancer cells.  J Biochem Mol Biol
2005, 38(6):639-645.
29. Mika S, Rost B: Protein-protein interactions more conserved
within species than across species.  PLoS Comput Biol 2006,
2(7):e79.
30. Matthews LR, Vaglio P, Reboul J, Ge H, Davis BP, Garrels J, Vincent S,
Vidal M: Identification of potential interaction networks using
sequence-based searches for conserved protein-protein
interactions or "interologs".  Genome Res 2001,
11(12):2120-2126.
31. Yu H, Luscombe NM, Lu HX, Zhu X, Xia Y, Han JD, Bertin N, Chung
S, Vidal M, Gerstein M: Annotation transfer between genomes:
protein-protein interologs and protein-DNA regulogs.
Genome Res 2004, 14(6):1107-1118.
32. Brown KR, Jurisica I: Online predicted human interaction data-
base.  Bioinformatics 2005, 21(9):2076-2082.
33. Lehner B, Fraser AG: A first-draft human protein-interaction
map.  Genome Biol 2004, 5(9):R63.
34. Han JD, Dupuy D, Bertin N, Cusick ME, Vidal M: Effect of sampling
on topology predictions of protein-protein interaction net-
works.  Nat Biotechnol 2005, 23(7):839-844.
35. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin
N, Schwikowski B, Ideker T: Cytoscape: a software environment
for integrated models of biomolecular interaction networks.
Genome Res 2003, 13(11):2498-2504.
36.  [http://www.analytictech.com/ucinet].
37. Montaner D, Tarraga J, Huerta-Cepas J, Burguet J, Vaquerizas JM,
Conde L, Minguez P, Vera J, Mukherjee S, Valls J, Pujana MA, Alloza E,
Herrero J, Al-Shahrour F, Dopazo J: Next station in microarray
data analysis: GEPAS.  Nucleic Acids Res 2006, 34(Web Server
issue):W486-91.
38. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP:
Summaries of Affymetrix GeneChip probe level data.  Nucleic
Acids Res 2003, 31(4):e15.
39. Al-Shahrour F, Minguez P, Vaquerizas JM, Conde L, Dopazo J: BABE-
LOMICS: a suite of web tools for functional annotation and
analysis of groups of genes in high-throughput experiments.
Nucleic Acids Res 2005, 33(Web Server issue):W460-4.
40. Freeman LC: A set of measures of centrality based on
betweenness.  Sociometry 1977, 40:35.
41. Sabidussi G: The centrality of a graph.  Psychometrika 1966,
31(4):581-603.
42. Burt RS: Structural Holes: The social structure of competi-
tion.  Cambridge , Harvard University Press; 1992. 
43. Bron C, Kerbosch J: Finding all cliques of an undirected graph.
Commun ACM 1973, 16(9):575-577.
44. Luce R, Perry A: A method of matrix analysis of group struc-
ture.  Psychometrika 1949, 14:95-116.
45. Website title [www.r-project.org].  .
46. Al-Shahrour F, Diaz-Uriarte R, Dopazo J: FatiGO: a web tool for
finding significant associations of Gene Ontology terms with
groups of genes.  Bioinformatics 2004, 20(4):578-580.